Table 2.
Means (standard deviations) for treatment outcomes divided by time and group
| Treatment group (n = 24) | Control group (n = 22) | |||||
|---|---|---|---|---|---|---|
| Measure | Baseline | Mid | After | Baseline | Mid | After |
| MADRS-S | 24.04 (7.46) | 13.38 (5.80) | 10.25 (7.56) | 20.77 (7.46) | 21.09 (6.67) | 19.09 (7.98) |
| PSWQ | 61.88 (11.21) | 56.21 (13.93) | 52.67 (12.25) | 57.95 (10.29) | 56.91 (10.54) | 54.68 (11.47) |
| GAD-Q-IV | 10.01 (2.20) | 7.75 (3.88) | 7.07 (3.02) | 9.92 (2.24) | 9.07 (2.88) | 9.22 (3.38) |
| PSQI | 10.58 (3.92) | 6.88 (4.05) | 5.71 (3.32) | 9.73 (3.49) | 9.18 (3.78) | 8.68 (4.08) |
| DERS | 99.67 (20.18) | 85.63 (22.55) | 83.04 (22.86) | 97.64 (20.33) | 98.86 (21.88) | 97.64 (21.43) |
| MAAS | 2.98 (0.65) | 3.37 (0.79) | 3.64 (1.06) | 3.64 (1.06) | 3.45 (0.72) | 3.35 (0.81) |
| EDN | 31.59 (15.43) | 45.48 (15.43) | 44.05 (16.25) | |||
Note. PSWQ Penn State Worry Questionnaire, GAD-Q-IV Dimensional scoring from the Generalized Anxiety Disorder Questionnaire, MADRS-S Montgomery-Asberg Depression Rating Scale, PSQI Pittsburgh Sleep Quality Index, DERS Dysfunctional Emotional Regulation Scale – Total mean score, MAAS Mindful Attention and Awareness Scale, EDN = Experienced deviation from normal state scale; Baseline = Before treatment; Mid = 4 weeks in treatment; After = Post-treatment